Vascular Effects of High-Salt After Preeclampsia
This study is looking into why women who have had preeclampsia (a serious blood pressure condition during pregnancy) might have a higher risk of heart problems later in life, especially how their bodies react to salt. Researchers are testing a drug called eplerenone to see how it affects blood vessel function in your skin when exposed to heat. They want to understand if problems with your blood vessels and a system in your body called the angiotensin system, which helps control blood pressure, are involved. To join, you must be a woman between 18 and 45 years old, and have given birth 12 weeks to 5 years ago, whether or not you had preeclampsia. The study aims to enroll 40 participants and is currently unclear about its recruitment status.
- Study design
- This is an interventional study planning to enroll 40 women. It compares the effects of eplerenone to a placebo (an inactive substance) on blood vessel function.
- What's involved
- You would undergo testing on Day 3 (while on a low-salt diet) and Day 10 (while on a low-salt diet with a high-salt supplement). You would also provide 24-hour urine samples on Day 2 and Day 9.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints are measured at Day 3 and Day 10, with urine samples collected on Day 2 and Day 9.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Vascular Effects of High-Salt After Preeclampsia
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Anna Reid-Stanhewicz, PhD · PRINCIPAL_INVESTIGATOR · University of Iowa
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in microvascular endothelial function following local eplerenone treatment compared to placebo treatment measured by laser-Doppler flowmetryDay 3 (low-salt diet run in) and Day 10 (low-salt diet + high-salt supplement)
Cutaneous vascular vasodilator response (cutaneous conductance; %max) to local heating of the skin; intradermal microdialysis for the local delivery of eplerenone compared to control (Ringer's solution), followed by L-NAME infusion to quantify NO-dependent response
- Changes in 24-hour urine sodiumDay 2, Day 9
The investigators will measure urine sodium to ensure differences in salt-take between low- and high-salt.